Blue Trust’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98 Buy
+4
New +$111 ﹤0.01% 2427
2025
Q4
– Sell
-9
Closed -$218 – 2549
2025
Q3
$218 Hold
9
– – ﹤0.01% 2510
2025
Q2
$153 Sell
9
-407
-98% -$7.09K ﹤0.01% 2397
2025
Q1
$8.12K Buy
416
+18
+5% +$472 ﹤0.01% 1985
2024
Q4
$9.9K Sell
398
-2,737
-87% -$69.9K ﹤0.01% 1893
2024
Q3
$73.5K Buy
3,135
+1,431
+84% +$37K ﹤0.01% 1391
2024
Q2
$56.3K Buy
1,704
+1,642
+2,648% +$40.3K ﹤0.01% 1206
2024
Q1
$2.05K Sell
62
-416
-87% -$13K ﹤0.01% 1823
2023
Q4
$11K Buy
+478
New +$11.9K ﹤0.01% 1534
2023
Q3
– Sell
-4
Closed – – 2039
2023
Q2
$0 Sell
4
-1
-20% -$32 ﹤0.01% 2034
2023
Q1
$0 Sell
5
-574
-99% -$22.7K ﹤0.01% 2307
2022
Q4
$28K Buy
579
+499
+624% +$22.4K ﹤0.01% 1153
2022
Q3
$3K Buy
80
+54
+208% +$3.08K ﹤0.01% 1665
2022
Q2
$1K Buy
+26
New +$1.03K ﹤0.01% 1744

Other funds holding BEAM

Blue Trust's BEAM Position: Q3 2026 in Review

Blue Trust opened a new position in Beam Therapeutics (BEAM) in Q3 2026: 4 shares worth $98. The stake represents ﹤0.01% of the portfolio and ranks #2427 among its holdings. This is a return to the name: Blue Trust previously reported a position in BEAM as recently as Q3 2025.

Blue Trust first reported a position in BEAM in Q2 2022 and has held it in 14 quarters since. The position peaked at $73.5K in Q3 2024. 196 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Blue Trust held 4 shares of Beam Therapeutics worth $98 as of Q3 2026.
  • Beam Therapeutics was a new Blue Trust position in Q3 2026.
  • Beam Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2427 holding.
  • Blue Trust first reported a position in Beam Therapeutics in Q2 2022 and has held it in 14 quarters since.
  • Blue Trust's Beam Therapeutics position peaked at $73.5K in Q3 2024.
  • 196 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.